An investigation of the impact of spot spacing on plan quality using IMPT optimization incorporating deliverable monitor unit constraints
Introduction
In current intensity modulated proton therapy (IMPT) treatment planning system (TPS), e.g., Eclipse v8.9 (Varian Medical Systems, Palo Alta, CA), the deliverable monitor unit (MU) constraints are not considered in the optimization routine. After optimized spot intensities, in proportion to MU values, are obtained, a post processing is performed to adjust spot intensities to meet the deliverable MU constraints. This post processing can result in significant distortion to optimized dose distributions, especially when spot spacing is small. Therefore, the ultimate impact of spot spacing on IMPT plan quality is difficult to evaluate. In this study, we propose an IMPT optimization method which incorporates deliverable monitor unit constraints so that the distortion effect of post processing is avoided and then the impact of spot spacing is studied.
Method and Materials
We introduce a two-stage linear programming (LP) based model to solve the deliverable spot intensity optimization (DSIO) problem by incorporating minimum MU constraints. A sub set of pre-arranged candidate spots are selected by the firststage LP solve without deliverable MU constraints, and intensities of selected spots are optimized in the second-stage LP solve with deliverable MU constraints. In addition, a quadratic programming (QP) based model to simulate the conventional spot intensity optimization (SCIO) without MU constraints is also studied. The implementation of DSIO and CSIO was entirely based on our in-house developed dose calculation engine. The LP was solved by CPLEX v12.1, and the QP is solved by the limited-memory Broyden-Fletcher-Goldfarb-Shannon (L-BFGS) algorithm.
Four prostate cancer cases selected at our institution were studied in this work. The prescription dose was 78 Gy (39 fractions), and two parallel opposed beam angles were planned for all cases. Plans optimized by both DSIO and CSIO were evaluated for different settings of spot spacing from 3 mm to 7 mm.
Results
Treatment plans optimized by DSIO and CSIO models were compared in this study. A comparison of dose volume histograms (DVHs) 
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Figure 3: Spot arrangement in an energy layer for CSIO and DISO optimized plans with spot spacing of 6 mm (the first row) and 4 mm (the second row) for one prostate cancer case.
of plans with the Eclipse default spot spacing (6.57 mm in this example) is shown in Figure 1 . The dose uniformity on the scanning target volume (STV) was equally good for both plans. While an advantage of the LP-based DSIO model on the rectum sparing was evident, a small advantage of the DSIO model on the bladder was also shown. Similar patterns were observed for all patient cases with all different spot spacings. Note that the dosimetric advantage of the DSIO model over CSIO is mainly because DSIO can eliminate the negative effect of post processing (for satisfying deliverable MU constraints) on plan quality for CSIO. Table 1 summarizes dose-volume statistic for DSIO optimized plans with different spot spacings for the four prostate cancer cases. All plans achieved 100% coverage of prescribed dose (78 Gy) on the STV. Although other metrics were improved by decreased spot spacing, the improvement was relatively marginal. For example, the V 70Gy for the rectum was averagely reduced by 3.1% by comparing plans with 7 mm and 3 mm spot spacing. In all, there was only minimal improvement achieved when spot spacing reduced below 4 mm.
In our patient studies, when spot spacing decreased, numbers of spots (with positive intensity) increased dramatically in CSIO optimized plans but only increased at a flat rate for DSIO plans. An example is shown in Figure  2 . Moreover, the spot arrangements in DSIO optimized plans were highly non-uniform. Figure 3 shows two examples of spot arrangement patterns in plans with 6 mm and 4 mm spot spacing. With almost the same number of deliverable spots in DISO optimized plans with both 6 mm and 4 mm spacing, the spots were located differently. This indicates that the number of deliverable spots required in LP optimized plans may be insensitive to changes of spot spacings. In addition, the gain of dosemetric improvement in plans optimized by the LP method was mainly because the automatic non-uniform arrangement of spot would have a larger degree of freedom while the total number of spots required kept nearly constant when spot spacing decreased.
Conclusions
The proposed DSIO method can firstly avoid the discrepancy between optimized and delivered plans in the current IMPT TPS, and secondly, allow the use of small spot spacings to improve target coverage and normal tissue sparing. Evaluations on four prostate cancer cases found that spot spacing less than 4 mm could not achieve pronounced dosimetric improvements.
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